# A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

> **NCT00234169** · PHASE1,PHASE2 · COMPLETED · sponsor: **Peter MacCallum Cancer Centre, Australia** · enrollment: 30 (actual)

## Conditions studied

- Multiple Myeloma
- Lymphoma

## Interventions

- **DRUG:** VTP195183

## Key facts

- **NCT ID:** NCT00234169
- **Lead sponsor:** Peter MacCallum Cancer Centre, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00234169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00234169, "A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00234169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*